Bekem Pharmaceutical Private Limited
About Bekem Pharmaceutical Private Limited
Data last updated:
Bekem Pharmaceutical Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U85191UP2016PTC076963. Its GSTIN is 09AAGCB6844A1ZT (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Qamar Abbas and Zaheer Abbas.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 444/234 H Baraf Khana Thakur Ganj, Lucknow, Uttar Pradesh, India – 226003.
As per the financials filed for FY 2023, the company reported a revenue of ₹84.01 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹31,097 (net margin 0.4%) and EBITDA of ₹50,196 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 75% over three years.
As per MCA filings, the company has open charges of ₹15 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address444/234 H Baraf Khana Thakur Ganj, Lucknow, Uttar Pradesh, India – 226003
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bekem Pharmaceutical Private Limited
The main business activity of Bekem Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bekem Pharmaceutical Private Limited FY 2023 filings available
Bekem Pharmaceutical Private Limited reported revenue of ₹84.01 Lakh (up 175% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Bekem Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 75% over three years, including 175% growth in the latest year. EBITDA rose 113% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bekem Pharmaceutical Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹50,196 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹31,097 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bekem Pharmaceutical Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bekem Pharmaceutical are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bekem Pharmaceutical Private Limited
Bekem Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amokha Drugs Private Limited | ₹84.53 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Kochi, Kerala, India |
| Asj Industries Private Limited | ₹84.44 Lakh (FY 2025) | •••• | •••• | -14.0% | •••• | Aurangabad, Maharashtra, India |
| Sparshmart Pharmaceuticals Private Limited | ₹84.34 Lakh (FY 2025) | •••• | •••• | 179.0% | •••• | New Delhi, Delhi, India |
| Rxcues Lifecare Private Limited | ₹84.25 Lakh (FY 2024) | •••• | •••• | 1.0% | •••• | Ahmedabad, Gujarat, India |
| Lifeway Pharmaceuticals Private Limited | ₹84.16 Lakh (FY 2024) | •••• | •••• | -42.0% | •••• | Hapur, Uttar Pradesh, India |
| Bekem Pharmaceutical Private Limited this company | ₹84.01 Lakh (FY 2023) | •••• | •••• | 175.0% | •••• | Lucknow, Uttar Pradesh, India |
| Placenta Pharmaceuticals Private Limited | ₹83.98 Lakh (FY 2022) | •••• | •••• | 128.0% | •••• | Chennai, Tamil Nadu, India |
| Evolva Biosciences Private Limited | ₹83.91 Lakh (FY 2024) | •••• | •••• | -21.0% | •••• | Jp Nagar, 8Th Phase, Karnataka, India |
| Reaxzen Healthcare Private Limited | ₹83.88 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Hyderabad, Telangana, India |
| Bevilin Pharma Private Limited | ₹83.77 Lakh (FY 2024) | •••• | •••• | 423.0% | •••• | Bangalore, Karnataka, India |
| Jydem Bio Pharma Private Limited | ₹83.77 Lakh (FY 2024) | •••• | •••• | 42.0% | •••• | Manimajra, Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Bekem Pharmaceutical by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Bekem Pharmaceutical Private Limited
Bekem Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Qamar Abbas | Director | 07 Mar 2016 | 10 Years 7 Months | Current |
| Zaheer Abbas | Director | 07 Mar 2016 | 10 Years 7 Months | Current |
Ownership and Shareholding of Bekem Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bekem Pharmaceutical Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Sep 2023 | Indian Bank | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Bekem Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Bekem Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bekem Pharmaceutical Private Limited
Bekem Pharmaceutical Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Qamar Abbas was appointed as Director on 07 Mar 2016.
Credit Ratings, Litigation & Regulatory Alerts for Bekem Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bekem Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bekem Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bekem Pharmaceutical Private Limited
Bekem Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCB6844A1ZT | Uttar Pradesh | Active | 08 Jan 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bekem Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bekem Pharmaceutical Private Limited
Bekem Pharmaceutical is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 March 2016 (10+ years old) and is registered under CIN U85191UP2016PTC076963.
Bekem Pharmaceutical reported revenue of ₹84.01 Lakh for FY 2023 (up 175% YoY).
Bekem Pharmaceutical has 2 current directors:
- Qamar Abbas - Director
- Zaheer Abbas - Director
Bekem Pharmaceutical reported a net profit of ₹31,097 (net margin 0.4%) and EBITDA of ₹50,196 (EBITDA margin 0.6%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Bekem Pharmaceutical is 75% over three years. In the latest year (FY 2023) revenue rose 175%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Bekem Pharmaceutical is 09AAGCB6844A1ZT, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Bekem Pharmaceutical is U85191UP2016PTC076963. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bekem Pharmaceutical was incorporated on 07 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Bekem Pharmaceutical by revenue are Amokha Drugs Private Limited, Asj Industries Private Limited, Sparshmart Pharmaceuticals Private Limited, Rxcues Lifecare Private Limited, Lifeway Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Qamar Abbas was appointed as Director on 07 Mar 2016. Zaheer Abbas was appointed as Director on 07 Mar 2016.
The registered office of Bekem Pharmaceutical is at 444234 H Baraf Khana Thakur Ganj, Lucknow, Uttar Pradesh, India – 226003.